Search results
Results From The WOW.Com Content Network
For more than 35 years, we've been tackling some of the world’s greatest public health challenges, revolutionizing HIV treatment and prevention and delivering a cure for hepatitis C.
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information.
Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers.
Grow Your Career at Gilead. With more than 18,000 employees spanning across 40+ countries on six continents, we have a global workforce dedicated to creating a better, healthier world for everyone. Explore Opportunities.
We’re working with organizations in Canada and around the world to eliminate healthcare inequities and promote social justice. At Gilead, we strive to transform and simplify care for people with life-threatening diseases around the world.
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2022. “2022 marked Gilead’s strongest full year growth in our base business since HCV sales peaked in 2015.
Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Follow our journey to create a healthier world for all people. Fueled by scientific innovation, we’re generating transformative medicines and cures across virology, oncology and inflammation.